What is the recommended follow-up/surveillance schedule following organ preservation treatment approach for cT1-2N0 rectal cancer?

Topics: Radiation Oncology • Gastrointestinal Cancers • Rectal Cancer • Medical Oncology • ASCO Journal Club

Taking into account follow up from NEO, OPERA and other organ preservation trials?

Answer from: Medical Oncologist at Community Practice

Patients with stage I rectal cancer treated with organ preservation require close surveillance to rule out tumor regrowth and local recurrence that may be salvaged with radical surgery. The highest risk of recurrence is within 2 years after completion of neoadjuvant therapy and patients should be fo...

Comments

Radiation Oncologist at West Virginia University
In our experience, insurers will not cover the rig...

Medical Oncologist at McLeod Regional Medical Center at McLeod Seacoast
An answer to this question would require a large a...

Answer from: Radiation Oncologist at Academic Institution

Here's what we know. Recurrences are often asymptomatic hence, it is unreliable to follow up based on symptoms alone. Besides, by the time recurrence become symptomatic, they are often locally advanced and not amenable for salvage. MRI (or EUS) is better than CT in evaluating rectal tumors espec...

Comments

Radiation Oncologist at Washington University School of Medicine
If you're following a patient with a T1 or T2 rect...

Related Questions